THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...
[19] The Federal Circuit clarified that a patent must specifically claim the active ingredient or its formulation, or an approved method of using the drug, in order to be eligible for listing in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback